# Evaluating the Efficacy and Safety of Daridorexant Transition From BZRAs in Insomnia Patients（EASY-TIP）

> **NCT07733414** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 156 (estimated)

## Conditions studied

- Insomnia Disorders

## Interventions

- **DRUG:** Daridorexant

## Key facts

- **NCT ID:** NCT07733414
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2029-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 156 (ESTIMATED)
- **Last updated:** 2026-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07733414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07733414, "Evaluating the Efficacy and Safety of Daridorexant Transition From BZRAs in Insomnia Patients（EASY-TIP）". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07733414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*